Table 3 Sample Characteristics
| Â | P-ICD 10-positive(N = 132) No. (%) | P-ICD 10-negative(N = 133) No. (%) | P-value |
|---|---|---|---|
Sex | Â | Â | Â |
   Male | 49 (37) | 44 (33) |  |
   Female | 83 (63) | 89 (67) |  |
Age | Â | Â | Â |
   > 70 | 36 (27) | 30 (23) |  |
   61-70 | 33 (25) | 28 (21) |  |
   51-60 | 37 (28) | 44 (33) |  |
   41-50 | 16 (12) | 21 (16) |  |
   31-40 | 8 (6) | 6 (5) |  |
   < 30 | 1 (1) | 2 (2) |  |
Education | Â | Â | Â |
   Did not receive education | 24 (18) | 16 (12) |  |
   Elementary | 42 (32) | 43 (32) |  |
   high school | 36 (27) | 38 (29) |  |
   College | 25 (19) | 29 (22) |  |
   College graduate | 1 (1) | 4 (3) |  |
   Missing | 4 | 3 |  |
Cancer diagnosis | Â | Â | Â |
   Head & Neck | 9 | 12 |  |
   Lung & Mediastinum | 12 | 16 |  |
   Breast | 39 | 58 | 0.033* |
   Liver | 5 | 5 |  |
   GI tract(except liver) | 29 | 15 | 0.035* |
   GU tract | 6 | 3 |  |
   GYN | 8 | 9 |  |
   Prostate | 7 | 2 |  |
   Hematological malignancy | 2 | 0 |  |
   Others | 10 | 13 |  |
   Missing | 2 | 3 |  |
Treatment Modalities | Â | Â | Â |
   Palliative treatment | 77 | 51 | 0.022* |
   Curative treatment | 18 | 38 | 0.088* |
   F/U after curative treatment | 35 | 43 |  |
Condition of the Disease | 23 | 0 | Â |
   No signs and symptoms | 30 | 51 | 0.02* |
   Stationary state | 13 | 20 |  |
   Progression (local invasion) | 35 | 18 | 0.02* |
   Progression (Metastasis) | 28 | 15 | 0.047* |
   Terminal stage | 27 | 21 |  |
   Missing | 5 | 2 |  |